CSI Market
Sign In | Register

Keenova Therapeutics Plc (MNK) Annual Balance Sheets

Annual · GAAP · USD millions
Access MNK quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Keenova Therapeutics Plc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 29 2023) (Dec 30 2022)
Assets
Cash & cash equivalent812.80
Cash & Short-term Investments812.00
Accounts receivable299.10
Inventories553.50
Other Current Assets0.00
Prepaid Expense And Other Assets Current254.90
Total Current Assets1,920.30
Equipment/Property/Plant Net185.40
Goodwill net31.80
Intangible Assets2,229.60
Other Assets, Noncurrent1,261.50
Total Assets5,628.60
Liabilities
Accounts Payable, Current AC77.90
Accrued Liabilities, Current120.70
Long-term Debt and Capital Lease Obligations, Current DE15.00
Other Liabilities, Current458.50
Total Current Liabilities672.10
Long-term debt2,532.30
Total Long-term Debt2,532.30
Combined Long+Short Total Debt (filer-reported)2,547.30
Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent PE0.00
Accrued Income Taxes, Noncurrent AC118.80
Other liabilities, Noncurrent112.50
Total Liabilities3,563.40
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2,115.50
Retained Earnings / Accumulated Deficit-51.70
Other Equity1.40
Common Stockholder's Equity2,065.20
Total Stockholder's Equity2,065.20
Liabilities & Stockholder's Equity5,628.60
4 historic quarters locked

Sign in to unlock the full Keenova Therapeutics Plc balance sheet history.

Sign In Create Free Account

About Keenova Therapeutics Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 15, 2026
  • Source: mnk-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-025238

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License